Bright Minds Biosciences Inc. (DRUG.CN)
Bright Minds Biosciences Inc., a biotechnology company, develops therapeutics to improve the lives of patients with severe and life-altering diseases in the United States.
100.42-0.04%Healthcare
StockGlow Score
Leaning Bearish
BearishBullish
1 year ago+124.7%
The outlook
Bright Minds Biosciences Inc. currently reads as leaning bearish based on below its 50- & 200-day averages, 44% of the way from its 52-week low to high, avg target +29% vs current price. This is a snapshot of current market data, not a forecast.
What’s behind the score
Price trendBelow its 50- & 200-day averages
52-week range44% of the way from its 52-week low to high
Price targetAvg target +29% vs current price
Analyst price target
~12-month · 3 analysts129.33average target+28.8% vs now
Now 100.42
Low 115.00High 147.00
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$985.3M
52-wk high
170.00
52-wk low
44.69
50-day avg
100.79
200-day avg
104.94
Trailing P/E
—